Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment.
Santini D, Armento G, Giusti R, Ferrara M, Moro C, Fulfaro F, Bossi P, Arena F, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Santini D, et al. Among authors: ferrara m. ESMO Open. 2020 Nov;5(6):e000933. doi: 10.1136/esmoopen-2020-000933. ESMO Open. 2020. PMID: 33208491 Free PMC article. No abstract available.
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.
Severi S, Bongiovanni A, Ferrara M, Nicolini S, Di Mauro F, Sansovini M, Lolli I, Tardelli E, Cittanti C, Di Iorio V, Mezzenga E, Scarpi E, Ibrahim T, Paganelli G, Zovato S. Severi S, et al. Among authors: ferrara m. ESMO Open. 2021 Aug;6(4):100171. doi: 10.1016/j.esmoop.2021.100171. Epub 2021 Jun 15. ESMO Open. 2021. PMID: 34139487 Free PMC article. Clinical Trial.
ALK inhibitors and advanced non-small cell lung cancer (review).
Rossi A, Maione P, Sacco PC, Sgambato A, Casaluce F, Ferrara ML, Palazzolo G, Ciardiello F, Gridelli C. Rossi A, et al. Int J Oncol. 2014 Aug;45(2):499-508. doi: 10.3892/ijo.2014.2475. Epub 2014 May 29. Int J Oncol. 2014. PMID: 24889366 Review.
New targeted therapies and small-cell lung cancer.
Rossi A, Maione P, Palazzolo G, Sacco PC, Ferrara ML, Falanga M, Gridelli C. Rossi A, et al. Among authors: ferrara ml. Clin Lung Cancer. 2008 Sep;9(5):271-9. doi: 10.3816/CLC.2008.n.042. Clin Lung Cancer. 2008. PMID: 18824449 Review.
New avenues for second-line treatment of metastatic non-small-cell lung cancer.
Gridelli C, Maione P, Rossi A, Falanga M, Bareschino M, Schettino C, Colantuoni G, Guerriero C, Nicolella D, Rossi E, Ferrara ML, Palazzolo G. Gridelli C, et al. Among authors: ferrara ml. Expert Rev Anticancer Ther. 2009 Jan;9(1):115-24. doi: 10.1586/14737140.9.1.115. Expert Rev Anticancer Ther. 2009. PMID: 19105711 Review.
1,118 results